NCT05119335 2025-11-12A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell CarcinomaNiKang Therapeutics, Inc.Phase 1/2 Terminated120 enrolled
NCT06939270 2025-04-22CD73/AXL Targeted HypoSti.CAR-T Cells in CD73/AXL Positive Advanced/Metastatic Solid TumorsChinese PLA General HospitalPhase 1/2 Not yet recruiting30 enrolled